Failure of initial antibacterial therapy costly

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.492, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PCR-guided pre-emptive antibacterial therapy less costly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 658, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Switch to lansoprazole: failure not more costly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Switch to lansoprazole: failure not more costly

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Congestive Heart Failure: What Should Be the Initial Therapy and Why?

By Chatterjee K.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Inappropriate therapy for MRSA costly, potentially deadly, problem

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite